A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN‐02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults

Publisher： John Wiley & Sons Inc

E-ISSN： 1526-4610|56|9|1455-1465

ISSN： 0017-8748

Source： HEADACHE, Vol.56, Iss.9, 2016-10, pp. : 1455-1465

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AVP‐825 Breath‐Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks

By  

HEADACHE, Vol. 55, Iss. 5, 2015-05 ,pp. : 621-635

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers

By  

EPILEPSIA, Vol. 56, Iss. 11, 2015-11 ,pp. : 1723-1731

John Wiley & Sons Inc

Access to resources Recommend Favorite

AVP‐825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical Trial

By  

HEADACHE, Vol. 58, Iss. 2, 2018-02 ,pp. : 229-242

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Efficacy of Propofol vs. Subcutaneous Sumatriptan for Treatment of Acute Migraine Headaches in the Emergency Department: A Double‐Blinded Clinical Trial

By  

PAIN PRACTICE, Vol. 15, Iss. 8, 2015-11 ,pp. : 701-705

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Luseogliflozin Dosing in Healthy Japanese Males: A Randomized, Single-Blind, Placebo-Controlled Trial

By Sasaki Takashi   Seino Yutaka   Fukatsu Atsushi   Sakai Soichi   Samukawa Yoshishige  

Advances in Therapy, Vol. 31, Iss. 3, 2014-03 ,pp. : 345-361

Springer Publishing Company

Access to resources Recommend Favorite